Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications

por Wolf, Melissa M., Rathmell, W. Kimryn, Beckermann, Kathryn E.
Publicado 2020

Emerging Targets in Clear Cell Renal Cell Carcinoma

por Chen, Yu-Wei, Rini, Brian I., Beckermann, Kathryn E.
Publicado 2022

Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant (INC) (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma

por Beckermann, Kathryn, Rini, Brian, Haas, Naomi, George, Daniel, Jonasch, Eric
Publicado 2023

Editorial: Case reports in renal cell carcinoma

por Zhuang, Tony Z., Mustafa, Seema M., Beckermann, Kathryn E., Bilen, Mehmet Asim
Publicado 2023

Spatial proteomics enables identification of prognostic biomarkers in papillary renal cell carcinoma

por Haake, Scott, Brewer, Jared, Nesta, Alex, Vento, Joseph, Beckermann, Kathryn, Reddy, Anupama
Publicado 2023

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

por Chen, Yu-Wei, Tucker, Matthew D., Beckermann, Kathryn E., Iams, Wade T., Rini, Brian I., Johnson, Douglas B.
Publicado 2021

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports

por Tucker, Matthew D., Beckermann, Kathryn E., Gordetsky, Jennifer B., Giannico, Giovanna A., Davis, Nancy B., Rini, Brian I.
Publicado 2020

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma

por Beckermann, Kathryn E., Jolly, Pradeep C., Kim, Ju Y., Bordeaux, Jennifer, Puzanov, Igor, Rathmell, W. Kimryn, Johnson, Douglas B.
Publicado 2017

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)

por Beckermann, Kathryn, Haake, Scott, Reddy, Anupama, Shyr, Yu, Kimryn Rathmell, W, Pal, Sumanta, Ornstein, Moshe, Barata, Pedro, Zhang, Tian, Rini, Brian
Publicado 2023

A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells

por Rasmussen, Megan L., Kline, Leigh A., Park, Kyungho P., Ortolano, Natalya A., Romero-Morales, Alejandra I., Anthony, Christin C., Beckermann, Kathryn E., Gama, Vivian
Publicado 2018

MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy

por Jiang, Xiaoyu, Dudzinski, Stephanie, Beckermann, Kathryn E, Young, Kirsten, McKinley, Eliot, McIntyre, J Oliver, Rathmell, Jeffrey C, Xu, Junzhong, Gore, John C
Publicado 2020

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

por Redman-Rivera, Lindsay N., Shaver, Timothy M., Jin, Hailing, Marshall, Clayton B., Schafer, Johanna M., Sheng, Quanhu, Hongo, Rachel A., Beckermann, Kathryn E., Wheeler, Ferrin C., Lehmann, Brian D., Pietenpol, Jennifer A.
Publicado 2021

SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-LINDAU DISEASE–ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS ENROLLED IN THE PHASE 2 LITESPARK-004 STUDY

por Narayan, Vivek, Iliopoulos, Othon, Iversen, Ane B, Maughan, Benjamin L, Beckermann, Kathryn E, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K, Fu, Wei, Perini, Rodolfo F, Liu, Yanfang, Linehan, W Marston, Srinivasan, Ramaprasad, Jonasch, Eric
Publicado 2023

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy

por Shiuan, Eileen, Beckermann, Kathryn E., Ozgun, Alpaslan, Kelly, Ciara, McKean, Meredith, McQuade, Jennifer, Thompson, Mary Ann, Puzanov, Igor, Greer, John P., Rapisuwon, Suthee, Postow, Michael, Davies, Michael A., Eroglu, Zeynep, Johnson, Douglas
Publicado 2017

CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation

por Beckermann, Kathryn E., Hongo, Rachel, Ye, Xiang, Young, Kirsten, Carbonell, Katie, Healey, Diana C. Contreras, Siska, Peter J., Barone, Sierra, Roe, Caroline E., Smith, Christof C., Vincent, Benjamin G., Mason, Frank M., Irish, Jonathan M., Rathmell, W. Kimryn, Rathmell, Jeffrey C.
Publicado 2020

Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial

por Larkin, James, Oya, Mototsugu, Martignoni, Marcella, Thistlethwaite, Fiona, Nathan, Paul, Ornstein, Moshe C, Powles, Thomas, Beckermann, Kathryn E, Balar, Arjun V, McDermott, David, Gupta, Sumati, Philips, George K, Gordon, Michael S, Uemura, Hirotsugu, Tomita, Yoshihiko, Wang, Jing, Michelon, Elisabete, di Pietro, Alessandra, Choueiri, Toni K
Publicado 2022

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma

por Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric
Publicado 2020

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma

por Wood, Christopher G., Ferguson, James E., Parker, Joel S., Moore, Dominic T., Whisenant, Jennifer G., Maygarden, Susan J., Wallen, Eric M., Kim, William Y., Milowsky, Mathew I., Beckermann, Kathryn E., Davis, Nancy B., Haake, Scott M., Karam, Jose A., Bortone, Dante S., Vincent, Benjamin G., Powles, Thomas, Rathmell, W. Kimryn
Publicado 2020

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

por Tucker, Matthew D., Brown, Landon C., Chen, Yu-Wei, Kao, Chester, Hirshman, Nathan, Kinsey, Emily N., Ancell, Kristin K., Beckermann, Kathryn E., Davis, Nancy B., McAlister, Renee, Schaffer, Kerry, Armstrong, Andrew J., Harrison, Michael R., George, Daniel J., Rathmell, W. Kimryn, Rini, Brian I., Zhang, Tian
Publicado 2021

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metas...

por Chen, Yu-Wei, Tucker, Matthew D., Brown, Landon C., Yasin, Hesham A., Ancell, Kristin K., Armstrong, Andrew J., Beckermann, Kathryn E., Davis, Nancy B., Harrison, Michael R., Kaiser, Elizabeth G., McAlister, Renee K., Schaffer, Kerry R., Wallace, Deborah E., George, Daniel J., Rathmell, W. Kimryn, Rini, Brian I., Zhang, Tian
Publicado 2022